Palivizumab |
Palivizumab Products |
| Palivizumab safely prevents RSV in infantile CHD.(AAP revises drug indications)(respiratory syncytial virus )(congenital heart disease): An article from: Pediatric News Damian McNamara International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| El virus de la incubadora. (palivizumab, para combatir el virus respiratorio sincitial en los bebés; incluye artículo relacionado)(TT: The incubator virus) ... related article): An article from: Epoca Jesús Ibáñez, Gabriel Plaza Difusora de Informacion Periodica, S.A. (DINPESA) Difusora de Informacion Periodica, S.A. (DINPESA) |
Sale Price: $5.95
|
| Palivizumab good for hospitalization prevention.('Real world' results against RSV): An article from: Pediatric News Damian McNamara International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Giving infants palivizumab at home improves compliance. (Respiratory Syncytial Virus Prophylaxis).: An article from: Pediatric News Miriam E. Tucker International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Palivizumab use leads to fewer rehospitalized preemies.(Infectious Diseases): An article from: Family Practice News Jeff Evans International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Palivizumab safe for infants with heart disease: monthly prophylaxis resulted in a 45% relative reduction in rate of hospitalizations.(Infectious Diseases): An article from: Family Practice News Damian McNamara International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Palivizumab protection against RSV better in real world than in trials: fewer hospitalizations.(Children's Health)(respiratory syncytial virus): An article from: Family Practice News Damian McNamara International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Palivizumab cuts RSV readmissions.(Infectious Diseases)(respiratory syncytial virus): An article from: Pediatric News Jeff Evans International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| RSV Infections between doeses of Palivizumab. (High-Risk candidates for RSV prophylaxis).(respiratory syncytial virus infections): An article from: Pediatric News Betsy Bates International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 


